Search company, investor...

Predict your next investment

amfund.com

Investments

6

Portfolio Exits

1

Funds

1

About AM Fund

Headquarters Location

Want to inform investors similar to AM Fund about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest AM Fund News

Ghanaian health tech startup mPharma secures $35million Series D funding for expansion

Jan 6, 2022

Ghanaian health tech startup mPharma has raised $35 million in a Series D round led by Citigroup Inc. Other investors that participated in the round include AM Fund, a venture capital firm founded by Tinder co-founder Justin Mateen, Unbound, a growth investment firm founded by Shravin Mittal, managing director Bharti Global Limited (Bharti family investment … The post Ghanaian health tech startup mPharma secures $35million Series D funding for expansion appeared first on TechTrendsKE.

AM Fund Investments

6 Investments

AM Fund has made 6 investments. Their latest investment was in Inhibitex as part of their Series C on June 6, 2000.

CBI Logo

AM Fund Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/12/2000

Series C

Inhibitex

$15M

Yes

5/1/2000

Series B

Subscribe to see more

$99M

Subscribe to see more

10

8/14/1998

Series B

Subscribe to see more

$99M

Subscribe to see more

0

6/24/1998

Series B

Subscribe to see more

$99M

Subscribe to see more

0

3/1/1998

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/12/2000

5/1/2000

8/14/1998

6/24/1998

3/1/1998

Round

Series C

Series B

Series B

Series B

Series A

Company

Inhibitex

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$15M

$99M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

10

0

0

10

AM Fund Portfolio Exits

1 Portfolio Exit

AM Fund has 1 portfolio exit. Their latest portfolio exit was Inhibitex on June 11, 2004.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/11/2004

IPO

$99M

Public

Date

6/11/2004

Exit

IPO

Companies

Valuation

$99M

Acquirer

Public

Sources

AM Fund Fund History

1 Fund History

AM Fund has 1 fund, including AM Fund LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/31/1994

AM Fund LP

Early-Stage Venture Capital

Closed

$14M

1

Closing Date

12/31/1994

Fund

AM Fund LP

Fund Type

Early-Stage Venture Capital

Status

Closed

Amount

$14M

Sources

1

AM Fund Team

2 Team Members

AM Fund has 2 team members, including current General Partner, Lloyd M Bentsen.

Name

Work History

Title

Status

Lloyd M Bentsen

Cogene Ventures

General Partner

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Lloyd M Bentsen

Subscribe to see more

Work History

Cogene Ventures

Title

General Partner

Subscribe to see more

Status

Current

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.